Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.25%
1,110.47
+13.75
+1.25%
—1,096.721,098.741,113.821,098.74——
SIXC
Communications
SIXC
Communications
SIXC
-1.19%
604.07
-7.25
-1.19%
—611.32611.32611.32603.33——
SIXE
Energy
SIXE
Energy
SIXE
+2.56%
1,201.49
+29.95
+2.56%
—1,171.541,176.151,202.381,176.15——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.01%
1,765.30
+17.67
+1.01%
—1,747.631,747.671,770.511,744.43——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
630.42
-1.07
-0.17%
—631.49631.23633.90627.95——
SIXR
Staples
SIXR
Staples
SIXR
-1.00%
841.45
-8.49
-1.00%
—849.94850.23850.23836.20——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.35%
218.83
+0.77
+0.35%
—218.06218.06219.96218.02——
SIXT
Technology
SIXT
Technology
SIXT
+1.31%
3,582.23
+46.20
+1.31%
—3,536.033,549.423,590.523,543.38——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.97%
913.89
+8.82
+0.97%
—905.07908.07916.83907.68——
SIXV
Health care
SIXV
Health care
SIXV
-0.38%
1,444.33
-5.53
-0.38%
—1,449.861,451.341,464.451,440.75——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,412.96
-17.51
-0.72%
—2,430.472,415.842,422.952,396.14——
HESTERBIO:NSE
Hester Biosciences Ltd
₹1,754.10
+1.36%
(+23.60) 1D
May 12, 12:39:29 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for HESTERBIO...
Open
₹1,750.30
High
₹1,815.60
Low
₹1,750.00
Mkt. cap
14.92B
Avg. vol.
4.78K
Volume
10.21K
Dividend
0.40%
Quarterly dividend
₹1.75
Ex dividend date
Aug 6, 2025
P/E ratio
46.55
52-wk high
₹2,350.00
52-wk low
₹1,239.30
EPS
₹37.69
Shares outstanding
8.51M
No. of employees
562
News stories
From sources across the web
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees562
Founded1983
Headquarters-
SectorBiotechnology
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
724.23M
864.21M
709.69M
774.15M
Cost of goods sold
252.56M
224.62M
193.19M
207.28M
Cost of revenue
252.56M
224.62M
193.19M
207.28M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
246.16M
152.82M
155.01M
155.18M
Operating expense
416.64M
430.11M
442.86M
433.25M
Total operating expenses
669.20M
654.73M
636.05M
640.53M
Operating income
55.03M
209.48M
73.64M
133.62M
Other non operating income
-4.86M
-
97.27M
6.69M
EBT including unusual items
37.45M
201.87M
170.36M
135.24M
EBT excluding unusual items
37.45M
201.87M
170.36M
135.24M
Income tax expense
22.04M
28.91M
27.05M
42.14M
Effective tax rate
58.85%
14.32%
15.88%
31.16%
Other operating expenses
128.72M
235.47M
244.31M
233.76M
Net income
12.91M
164.42M
144.49M
87.65M
Net profit margin
1.78%
19.03%
20.36%
11.32%
Earnings per share
-
-
-
-
Interest and investment income
20.37M
-
-
-
Interest expense
-12.57M
-18.10M
-22.07M
-18.22M
Net interest expenses
7.80M
-18.10M
-22.07M
-18.22M
Depreciation and amortization charges
41.76M
41.82M
43.54M
44.31M
EBITDA
96.07M
250.52M
116.32M
174.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer